Investors in TauRx Pharma have exercised warrants worth around $119 million, adding to the biotech's financial resources as it prepares regulatory filings for tau-targeting Alzheimer's drug ...
TV and home video editor Ty Pendlebury joined CNET Australia in 2006, and moved to New York City to be a part of CNET in 2011. He tests, reviews and writes about the latest TVs and audio equipment.
Everything you need to be prepared for launch in March. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results